The most effective biomarker for discriminating between control participants and patients with glaucoma was the serum MBP level with the cut off value of 183.4pg/ml, while for discriminating between patients with NTG and HTG it was the serum anti-SSB level with the cut off value of 0.962. This evidence concerns the gene MBP and glaucoma.